nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - Önnur meltingarvegi og efnaskipti vörur, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.
thalidomide lipomed
lipomed gmbh - dauða - mergæxli - Ónæmisbælandi lyf - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
eladynos
theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalsíumsterastasis - meðferð beinþynningar hjá konum eftir tíðahvörf við aukna hættu á beinbrotum.
midazolam medical valley munnholslausn 2,5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 2,5 mg
midazolam medical valley munnholslausn 7,5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 7,5 mg
icatibant stada stungulyf, lausn í áfylltri sprautu 30 mg
stada arzneimittel ag - icatibantum inn - stungulyf, lausn í áfylltri sprautu - 30 mg
midazolam medical valley munnholslausn 5 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 5 mg
epipen stungulyf, lausn 300 míkróg
viatris aps - adrenalinum (epinephrinum inn) - stungulyf, lausn - 300 míkróg
epipen jr. stungulyf, lausn 150 míkróg
viatris aps - adrenalinum (epinephrinum inn) - stungulyf, lausn - 150 míkróg
midazolam medical valley munnholslausn 10 mg
medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 10 mg